Hrt Financial LP Rapt Therapeutics, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$6.87 - $26.45 $280,783 - $1.08 Million	40,871 New	40,871 $367,000
Q3 2021 Nov 15, 2021	SELL	$29.86 - $39.47 $534,225 - $706,157	-17,891 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.99 - $40.02 $61,237 - $136,228	-3,404 Reduced 15.98%	17,891 $568,000
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $340,720 - $520,875	21,295 New	21,295 $472,000

125

29.1M

905K

592K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $59.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.